TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas

Clinical trial NCT07082803 · RECRUITING

Trial details

NCT number: NCT07082803
Sponsor: Treeline Biosciences, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoma Lymphoma, Non Hodgkin

Start date: 2025-06-23
Primary completion: 2030-09-01
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.